Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 3Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 4Venous Thrombosis 2Venous Thromboembolism 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Thrombosis 1Thromboembolism 1Stomach Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Multiple Myeloma 1Lung Neoplasms 1Inflammation 1Immune System Diseases 1Glioma 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Dyskinesias 1Duodenal Neoplasms 1Cholangiocarcinoma 1Cardiovascular Diseases 1Breast Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Rivaroxaban 2apixaban 1Tinzaparin 1Laparoscopy 1Imaging, Three-Dimensional 1Hospitals 1Heparin, Low-Molecular-Weight 1Fluorodeoxyglucose F18 1Enoxaparin 1Dabigatran 1Conversion to Open Surgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Venous Thrombosis × Rivaroxaban × Clear all
NCT05303818 2022-03-31

Ésquilo

Hospital do Servidor Publico Estadual

Phase 4 Unknown
68 enrolled
Gastrointestinal

Colonic Neoplasms, Venous Thrombosis

NCT04309240 2020-03-16

Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports

LiuZhou People's Hospital

Phase 3 Unknown
204 enrolled

Neoplasms, Venous Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡